Reply to: Caution is warranted in using cephamycin antibiotics against recurrent Clostridioides difficile infection

Affiliations

¹ Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia. dena.lyras@monash.edu.
² Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia.

Comment

Dena Lyras et al. Nat Microbiol. 2020 Feb.

. 2020 Feb;5(2):237-238.

doi: 10.1038/s41564-019-0662-8. Epub 2020 Jan 27.

¹ Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia. dena.lyras@monash.edu.
² Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia.

No abstract available

Comment on

Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection.
Srikhanta YN, Hutton ML, Awad MM, Drinkwater N, Singleton J, Day SL, Cunningham BA, McGowan S, Lyras D. Srikhanta YN, et al. Nat Microbiol. 2019 Dec;4(12):2237-2245. doi: 10.1038/s41564-019-0519-1. Epub 2019 Aug 12. Nat Microbiol. 2019. PMID: 31406331
Caution is warranted in using cephamycin antibiotics against recurrent Clostridioides difficile infection.
Wilcox MH. Wilcox MH. Nat Microbiol. 2020 Feb;5(2):236. doi: 10.1038/s41564-019-0661-9. Epub 2020 Jan 27. Nat Microbiol. 2020. PMID: 31992895 No abstract available.

1. Wilcox, M. H. Caution is warranted in using cephamycin antibiotics against recurrent Clostridioides difficile infection. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0661-9 (2020).
1. Srikhanta, Y. N. et al. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection. Nat. Microbiol. 4, 2237–2245 (2019). - DOI
1. Hill, J. A. & Cowen, L. E. Using combination therapy to thwart drug resistance. Future Microbiol. 10, 1719–1726 (2015). - DOI
1. Tyers, M. & Wright, G. D. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 17, 141–155 (2019). - DOI
1. Cottarel, G. & Wierzbowski, J. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol. 25, 547–555 (2007). - DOI